A Phase 2b, Randomized, Double-Mask, Placebo-Controlled, Study to Evaluate the Safety, Pharmacokinetics and Efficacy of Linsitinib in Subjects with Active, Moderate to Severe Thyroid Eye Disease (TED)
100 Clinical Results associated with Vasaragen, Inc.
0 Patents (Medical) associated with Vasaragen, Inc.
100 Deals associated with Vasaragen, Inc.
100 Translational Medicine associated with Vasaragen, Inc.